Sugar-Grafted Cyclodextrin Nanocarrier as a "Trojan Horse" for Potentiating Antibiotic Activity
详细信息 查看全文
- 作者：Min Li ; Koon Gee Neoh ; Liqun Xu ; Liang Yuan ; David Tai Leong…
- 刊名：Pharmaceutical Research
- 出版年：2016
- 出版时间：May 2016
- 年：2016
- 卷：33
- 期：5
- 页码：1161-1174
- 全文大小：828 KB
- 参考文献：1.Chang HH, Cohen T, Grad YH, Hanage WP, O’Brien TF, Lipsitch M. Origin and proliferation of multiple-drug resistance in bacterial pathogens. Microbiol Mol Biol Rev. 2015;79(1):101–16.CrossRef PubMed PubMedCentral
2.Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep. 2007;122(2):160–6.PubMed PubMedCentral
3.Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis. 2007;13(12):1840–6.CrossRef PubMed PubMedCentral
4.Andersson DI, Hughes D. Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol Rev. 2011;35(5):901–11.CrossRef PubMed
5.Boucher HW, Talbot GH, Benjamin DK, Bradley J, Guidos RJ, Jones RN, et al. 10 x ′20 Progress-development of new drugs active against Gram-negative bacilli: an update from the infectious diseases society of america. Clin Infect Dis. 2013;56(12):1685–94.CrossRef PubMed PubMedCentral
6.Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013;65(13–14):1803–15.CrossRef PubMed
7.Adhikari MD, Goswami S, Panda BR, Chattopadhyay A, Ramesh A. Membrane-directed high bactericidal activity of (gold nanoparticle)polythiophene composite for niche applications against pathogenic bacteria. Adv Healthc Mater. 2013;2(4):599–606.CrossRef PubMed
8.Quinn JF, Whittaker MR, Davis TP. Delivering nitric oxide with nanoparticles. J Control Release. 2015;205:190–205.CrossRef PubMed
9.Seleem MN, Jain N, Pothayee N, Ranjan A, Riffle JS, Sriranganathan N. Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline. FEMS Microbiol Lett. 2009;294(1):24–31.CrossRef PubMed
10.Zhao L, Zhu BY, Jia YH, Hou WJ, Su C. Preparation of biocompatible carboxymethyl chitosan nanoparticles for delivery of antibiotic drug. Biomed Res Int. 2013;13:Article ID 236469, 236467 pages.
11.Qiu ZG, Yu YM, Chen ZL, Jin M, Yang D, Zhao ZG, et al. Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera. Proc Natl Acad Sci U S A. 2012;109(13):4944–9.CrossRef PubMed PubMedCentral
12.Chilajwar SV, Pednekar PP, Jadhav KR, Gupta GJC, Kadam VJ. Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery. Expert Opin Drug Deliv. 2014;11(1):111–20.CrossRef PubMed
13.Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem. 2004;39(9):1033–46.CrossRef
14.Bouckaert J, Li Z, Xavier C, Almant M, Caveliers V, Lahoutte T, et al. Heptyl α-D-mannosides grafted on a β-cyclodextrin core to interfere with Escherichia coli adhesion: an in vivo multivalent effect. Chem Eur J. 2013;19(24):7847–55.CrossRef PubMed
15.Rulis AM. USFDA agency response letter GRAS notice no. GRN 000074. Available from: http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm154182.htm .
16.Postma PW, Lengeler JW. Phosphoenolpyruvate - carbohydrate phosphotransferase system of bacteria. Microbiol Rev. 1985;49(3):232–69.PubMed PubMedCentral
17.Kumar A, Chua KL, Schweizer HP. Method for regulated expression of single-copy efflux pump genes in a surrogate Pseudomonas aeruginosa strain: identification of the BpeEF-OprC chloramphenicol and trimethoprim efflux pump of Burkholderia pseudomallei 1026b. Antimicrob Agents Chemother. 2006;50(10):3460–3.CrossRef PubMed PubMedCentral
18.Zhang Q, Slavin S, Jones MW, Haddleton AJ, Haddleton DM. Terminal functional glycopolymers via a combination of catalytic chain transfer polymerisation (CCTP) followed by three consecutive click reactions. Polym Chem. 2012;3(4):1016–23.CrossRef
19.Ashton PR, Koniger R, Stoddart JF, Alker D, Harding VD. Amino acid derivatives of beta-cyclodextrin. J Org Chem. 1996;61(3):903–8.CrossRef
20.Mariappan TT, Jindal KC, Singh S. Overestimation of rifampicin during colorimetric analysis of anti-tuberculosis products containing isoniazid due to formation of isonicotinyl hydrazone. J Pharm Biomed Anal. 2004;36(4):905–8.CrossRef PubMed
21.Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48:5–16.CrossRef PubMed
22.Xu LQ, Wang L, Zhang B, Lim CH, Chen Y, Neoh KG, et al. Functionalization of reduced graphene oxide nanosheets via stacking interactions with the fluorescent and water-soluble perylene bisimide-containing polymers. Polymer. 2011;52(11):2376–83.CrossRef
23.Richmond GE, Chua KL, Piddock LJV. Efflux in Acinetobacter baumannii can be determined by measuring accumulation of H33342 (bis-benzamide). J Antimicrob Chemother. 2013;68(7):1594–600.CrossRef PubMed PubMedCentral
24.Hüttel R. Über einige aldehyde der pyrazol- und der 1.2.3-triazol-reihe. Chem Ber. 1941;74(10):1680–7.CrossRef
25.Tang W, Becker ML. “Click” reactions: a versatile toolbox for the synthesis of peptide-conjugates. Chem Soc Rev. 2014;43(20):7013–39.CrossRef PubMed
26.Xu J, Liu SY. Synthesis of well-defined 7-arm and 21-arm poly (n-isopropylacrylamide) star polymers with beta-cyclodextrin cores via click chemistry and their thermal phase transition behavior in aqueous solution. J Polym Sci Part A: Polym Chem. 2009;47(2):404–19.CrossRef
27.Theocharis AB, Alexandrou NE. Synthesis and spectral data of 4,5-bis[5-aryl-1,3,4-oxadiazol-2-yl]-1-benzyl-1,2,3-triazoles. J Heterocycl Chem. 1990;27(6):1685–8.CrossRef
28.Song W, Yu XW, Wang SX, Blasier R, Markel DC, Mao GZ, et al. Cyclodextrin-erythromycin complexes as a drug delivery device for orthopedic application. Int J Nanomedicine. 2011;6:3173–86.PubMed PubMedCentral
29.Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. The European Committee on Antimicrobial Susceptibility Testing.; Available from: http://www.eucast.org/clinical_breakpoints/ .
30.Roberts MC. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol Lett. 2008;282(2):147–59.CrossRef PubMed
31.Fowler VG, Proctor RA. Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect. 2014;20(S5):66–75.CrossRef PubMed PubMedCentral
32.Singh R, Smitha MS, Singh SP. The role of nanotechnology in combating multi-drug resistant bacteria. J Nanosci Nanotechnol. 2014;14(7):4745–56.CrossRef PubMed
33.Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins.1. Drug solubilization and stabilization. J Pharm Sci. 1996;85(10):1017–25.CrossRef PubMed
34.Oldfield E, Feng XX. Resistance-resistant antibiotics. Trends Pharmacol Sci. 2014;35(12):664–74.CrossRef PubMed PubMedCentral
35.Athanassiou G, Michaleas S, Lada-Chitiroglou E, Tsitsa T, Antoniadou-Vyza E. Antimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance. J Pharm Pharmacol. 2003;55(3):291–300.CrossRef PubMed
36.Pajatsch M, Andersen C, Mathes A, Bock A, Benz R, Engelhardt H. Properties of a cyclodextrin-specific, unusual porin from Klebsiella oxytoca. J Biol Chem. 1999;274(35):25159–66.CrossRef PubMed
37.Fetzner A, Bohm S, Schreder S, Schubert R. Degradation of raw or film-incorporated beta-cyclodextrin by enzymes and colonic bacteria. Eur J Pharm Biopharm. 2004;58(1):91–7.CrossRef PubMed
38.Piatkowska E, Piatkowski J, Przondo-Mordarska A. The strongest resistance of Staphylococcus aureus to erythromycin is caused by decreasing uptake of the antibiotic into the cells. Cell Mol Biol Lett. 2012;17(4):633–45.CrossRef PubMed
39.Steffansen B, Bundgaard H. Erythromycin prodrugs - kinetics of hydrolysis of erythromycin and various erythromycin 2′-esters in aqueous-solution and human-plasma. Int J Pharm. 1989;56(2):159–68.CrossRef
40.Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 2009;17(2):153–62.CrossRef PubMed - 作者单位：Min Li (1)
Koon Gee Neoh (1)
Liqun Xu (1)
Liang Yuan (1)
David Tai Leong (1)
En-Tang Kang (1)
Kim Lee Chua (2)
Li Yang Hsu (3)
1. Department of Chemical and Biomolecular Engineering, National University of Singapore, Kent Ridge,, Singapore, 117585, Singapore
2. Department of Biochemistry, National University of Singapore, Kent Ridge,, Singapore, 117543, Singapore
3. Department of Medicine, National University of Singapore, Kent Ridge, Singapore, 119228, Singapore - 刊物类别：Biomedical and Life Sciences
- 刊物主题：Biomedicine
Pharmacology and Toxicology
Pharmacy
Biochemistry
Medical Law
Biomedical Engineering - 出版者：Springer Netherlands
- ISSN：1573-904X
文摘